Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drug.
about
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.Improved anti-tumor activity of stabilized anthracycline polymeric micelle formulation, NC-6300.Protamylasse, a residual compound of industrial starch production, provides a suitable medium for large-scale cyanophycin production.Engineering the genotype of Acinetobacter sp. strain ADP1 to enhance biosynthesis of cyanophycinThe optimization of polymalic acid peptide copolymers for endosomolytic drug delivery.Polyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations.
P2860
Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drug.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Poly-L-aspartic acid as a carr ...... f free and polymer-bound drug.
@ast
Poly-L-aspartic acid as a carr ...... f free and polymer-bound drug.
@en
type
label
Poly-L-aspartic acid as a carr ...... f free and polymer-bound drug.
@ast
Poly-L-aspartic acid as a carr ...... f free and polymer-bound drug.
@en
prefLabel
Poly-L-aspartic acid as a carr ...... f free and polymer-bound drug.
@ast
Poly-L-aspartic acid as a carr ...... f free and polymer-bound drug.
@en
P2093
P2860
P356
P1476
Poly-L-aspartic acid as a carr ...... f free and polymer-bound drug.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1985.267
P407
P577
1985-12-01T00:00:00Z